Kaempferia parviflora Ethanol Extract, a Peroxisome Proliferator-Activated Receptor Ligand-binding Agonist, Improves Glucose Tolerance and Suppresses Fat Accumulation in Diabetic NSY Mice

被引:20
|
作者
Ochiai, Masaru [1 ]
Takeuchi, Toshiki [2 ]
Nozaki, Tsutomu [3 ]
Ishihara, Ken-o [3 ]
Matsuo, Tatsuhiro [2 ]
机构
[1] Kitasato Univ, Sch Vet Med, 23-35-1 Higashi, Towada, Aomori 0348628, Japan
[2] Kagawa Univ, Fac Agr, Kita Ku, 2393 Ikenobe, Miki, Kagawa 7610795, Japan
[3] BHN Co Ltd, Chiyoda Ku, 1-16 Kandanishiki, Tokyo 1010054, Japan
关键词
fat accumulation; glucose tolerance; Kaempferia parviflora; methoxy flavone; PPAR; ETHYL-ACETATE EXTRACT; TISSUE DISTRIBUTION; INSULIN-RESISTANCE; PANCREATIC LIPASE; PPAR-GAMMA; 5,7-DIMETHOXYFLAVONE; MOUSE; RAT; POLYMETHOXYFLAVONOIDS; PHARMACOKINETICS;
D O I
10.1111/1750-3841.14437
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
This study assessed the effect of Kaempferia parviflora, also known as black ginger (BG), and its ethanol extract (BGE) on peroxisome proliferator-activated receptor (PPAR) agonistic activity, glucose tolerance, fat accumulation, and lipids-induced hypertriglyceridemia in mice. PPAR ligand-binding capacity in vitro and polymethoxy flavone contents were highly observed in organic solvent extracts. In an animal experiment A, male diabetic Nagoya-Shibata-Yasuda mice were divided into five dietary groups and fed each diet for 8 weeks: AIN-93G diet (low-fat [LF] diet), high-fat (HF) diet, HF diet supplemented with 1% BG, HF diet supplemented with 0.19% BGE, and HF diet supplemented with pioglitazone (PPAR agonist, 3 mg/kg/day) as a PPAR agonistic positive control. As determined from glucose and insulin tolerance tests, plasma glucose levels were improved in the BG and BGE groups. The BGE extract suppressed fat accumulation in adipose tissues, liver, and muscles without changing the plasma adiponectin level. In an animal experiment B, in order to investigate the effect of BG and BGE on lipid-induced hypertriglyceridemia, male ddY mice were divided into three test groups: control, BG-administered group (500 mg/kg), and BGE-administered group (100 mg/kg). The plasma triacylglycerol level was not different among the groups during the lipids administration test. These results conclude that the BGE extract containing several kinds of polymethoxy flavones showed PPAR ligand-binding capacity in vitro and prevented obesity and insulin resistance independent of adiponectin secretion in mice.
引用
收藏
页码:339 / 348
页数:10
相关论文
共 29 条
  • [21] Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
    B. Fagerberg
    S. Edwards
    T. Halmos
    J. Lopatynski
    H. Schuster
    S. Stender
    G. Stoa-Birketvedt
    S. Tonstad
    S Halldórsdóttir
    I. Gause-Nilsson
    Diabetologia, 2005, 48 : 1716 - 1725
  • [22] Chrysanthemum morifolium extract attenuates high-fat milk-induced fatty liver through peroxisome proliferator-activated receptor α-mediated mechanism in mice
    Cui, Yan
    Wang, Xiaoli
    Xue, Jie
    Liu, Jiangyun
    Xie, Meilin
    NUTRITION RESEARCH, 2014, 34 (03) : 268 - 275
  • [23] Boehmeria nivea Stimulates Glucose Uptake by Activating Peroxisome Proliferator-Activated Receptor Gamma in C2C12 Cells and Improves Glucose Intolerance in Mice Fed a High-Fat Diet
    Kim, Sung Hee
    Sung, Mi Jeong
    Park, Jae Ho
    Yang, Hye Jeong
    Hwang, Jin-Taek
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [24] Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
    Fagerberg, B
    Edwards, S
    Halmos, T
    Lopatynski, J
    Schuster, H
    Stender, S
    Stoa-Birketvedt, G
    Tonstad, S
    Halldórsdóttir, S
    Gause-Nilsson, I
    DIABETOLOGIA, 2005, 48 (09) : 1716 - 1725
  • [25] The Ras Inhibitors Caveolin-1 and Docking Protein 1 Activate Peroxisome Proliferator-Activated Receptor γ through Spatial Relocalization at Helix 7 of Its Ligand-Binding Domain
    Burgermeister, Elke
    Friedrich, Teresa
    Hitkova, Ivana
    Regel, Ivonne
    Einwaechter, Henrik
    Zimmermann, Wolfgang
    Roecken, Christoph
    Perren, Aurel
    Wright, Matthew B.
    Schmid, Roland M.
    Seger, Rony
    Ebert, Matthias P. A.
    MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (16) : 3497 - 3510
  • [26] Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes
    Zheng, W.
    Feng, X.
    Qiu, L.
    Pan, Z.
    Wang, R.
    Lin, S.
    Hou, D.
    Jin, L.
    Li, Y.
    DIABETOLOGIA, 2013, 56 (02) : 401 - 411
  • [27] A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice
    Shiomi, Yoshihiro
    Yamauchi, Toshimasa
    Iwabu, Masato
    Okada-Iwabu, Miki
    Nakayama, Ryo
    Orikawa, Yuki
    Yoshioka, Yoshichika
    Tanaka, Koichiro
    Ueki, Kohjiro
    Kadowaki, Takashi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (23) : 14567 - 14581
  • [28] Suppression of Peroxisome Proliferator-Activated Receptor γ-Coactivator-1α Normalizes the Glucolipotoxicity-Induced Decreased BETA2/NeuroD Gene Transcription and Improved Glucose Tolerance in Diabetic Rats
    Kim, Ji-Won
    You, Young-Hye
    Ham, Dong-Sik
    Cho, Jae-Hyoung
    Ko, Seung-Hyun
    Song, Ki-Ho
    Son, Ho-Young
    Suh-Kim, Haeyoung
    Lee, In-Kyu
    Yoon, Kun-Ho
    ENDOCRINOLOGY, 2009, 150 (09) : 4074 - 4083
  • [29] Quantitative image analysis in adipose tissue using an automated image analysis system:: Differential effects of peroxisome proliferator-activated receptor-α and -γ agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice
    Okamoto, Yuji
    Higashiyama, Hiroyuki
    Inoue, Hiroki
    Kanematsu, Masahiro
    Kinoshita, Mine
    Asano, Satoshi
    PATHOLOGY INTERNATIONAL, 2007, 57 (06) : 369 - 377